Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines.

Abstract

Melanoma is an aggressive cutaneous cancer, whose incidence is growing in recent years, especially in the younger population. The favorable therapy for this neoplasm consists in its early surgical excision; otherwise, in case of late diagnosis, melanoma becomes very refractory to any conventional therapy. Nevertheless, the acute inflammatory response occurring after excision of the primary melanoma can affect the activation and/or regulation of melanoma invasion and metastasis. Nonsteroidal anti-inflammatory drugs (NSAIDs), widely employed in clinical therapy as cyclooxygenase inhibitors, also display a cytotoxic effect on some cancer cell lines; therefore, their possible usage in combination with conventional chemo- and radio-therapies of tumors is being considered. In particular, diclofenac, one of the most common NSAIDs, displays its anti-proliferative effect in many tumor lines, through an alteration of the cellular redox state. In this study, the possible anti-neoplastic potential of diclofenac on the human melanoma cell lines A2058 and SAN was investigated, and a comparison was made with the results obtained from the nonmalignant fibroblast cell line BJ-5ta. Either in A2058 or SAN, the diclofenac treatment caused typical apoptotic morphological changes, as well as an increase of the number of sub-diploid nuclei; conversely, the same treatment on BJ-5ta had only a marginal effect. The observed decrease of Bcl-2/Bax ratio and a parallel increase of caspase-3 activity confirmed the pro-apoptotic role exerted by diclofenac in melanoma cells; furthermore, the drug provoked an increase of the ROS levels, a decrease of mitochondrial superoxide dismutase (SOD2), the cytosolic translocation of both SOD2 and cytochrome c, and an increase of caspase-9 activity. Finally, the cytotoxic effect of diclofenac was amplified, in melanoma cells, by the silencing of SOD2. These data improve the knowledge on the effects of diclofenac and suggest that new anti-neoplastic treatments should be based on the central role of mitochondrion in cancer development; under this concern, the possible involvement of SOD2 as a novel target could be considered.

• Authors: Francesco Albano, Alessandro Arcucci, Giuseppina Granato, Simona Romano, Stefania Montagnani, Emmanuele De Vendittis, Maria Rosaria Ruocco
• Journal: Biochimie (Biochimie) Vol. 95 Issue 4 Pg. 934-45 (Apr 2013) ISSN: 1638-6183 [Electronic] France
• PMID: 23274131 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Biomarkers, Tumor
• Reactive Oxygen Species
• Diclofenac
• Cytochromes c
• Superoxide Dismutase
• superoxide dismutase 2
• Caspase 9

Topics

• Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
• Apoptosis (drug effects)
• Biomarkers, Tumor (metabolism)
• Caspase 9 (metabolism)
• Cell Line, Tumor
• Cytochromes c (metabolism)
• Diclofenac (pharmacology)
• Enzyme Activation (drug effects)
• Humans
• Melanoma (pathology)
• Mitochondria (drug effects, metabolism)
• Reactive Oxygen Species (metabolism)
• Superoxide Dismutase (metabolism)